The nation of Zimbabwe has declined a major American health deal worth 367 million US dollars (272 million pounds) spanning five years due to Washington's insistence on sensitive data.
This rejection came to light following a official document from December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".
A government spokesperson has since clarified that the US was requesting health data for research and commercial gain while refused to share the benefits from any future vaccines.
"We are forced to start the difficult and regrettable process of winding down our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had provided more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for more dialogue to secure a agreement acceptable to both sides so the nation's critical HIV programme can proceed.
Broader Background
This development follows a comparable situation in Kenya, where a high court blocked a related deal with the US after concerns were raised about the safety of citizens' medical information.
After returning to office last year, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
USAID had overseen assistance for the American government, but Trump stated its expenditure was "inefficient" and his government was pursuing direct bilateral agreements to boost openness and accountability.
As per reports, Sixteen nations in Africa have so far signed similar agreements, representing more than $18.3bn in new funding.
Specifics of the Rejected Agreement
This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this collaboration could have provided significant advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded programmes," Tremont added.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"Our nation was requested to provide its biological resources and data for a long time, with no corresponding promise of benefiting from any medical innovations – like new medicines or tests – that might result from that provided information," he stated.
"In essence, our country would provide the raw materials for scientific discovery without any assurance that the resulting innovations would be available to our citizens if a new health crisis arise."
Sovereignty and Global Health
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were disrupting frameworks previously set up through the global health agency.
The spokesperson cited its Pandemic Benefit-Sharing framework created to manage potential pandemics.
"This mechanism is designed to ensure that when a country contributes its data, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to create them."
The government's concerns regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We welcome continued discussions with our American counterparts on how future collaboration could be designed in a way that honours the sovereignty and dignity of both nations."
Health Experts Reaction
A leading public health body said it acknowledged the government's concerns, but urged that negotiations must proceed since a large portion of the nation's Aids initiatives were funded by external financing.
"Where specific concerns arise, including those relating to information security or implementation frameworks, these can frequently be addressed through detailed discussion and negotiated safeguards," it added.
The halted deal emphasises the ongoing challenges between receiving crucial international aid and safeguarding local interests in an ever more interconnected world.